Pacific Biosciences Of California (PACB) Convertible Debt (2021 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Convertible Debt of $644.1 million for Q1 2026, little changed year-over-year from $646.2 million in Q1 2025, and little changed quarter-over-quarter from $645.4 million in Q4 2025.
Pacific Biosciences Of California (PACB) Convertible Debt (2021 - 2026) Analysis & Trends
Pacific Biosciences Of California's Convertible Debt history runs 6 years deep, the most recent figure standing at $644.1 million for Q1 2026.
- In Q1 2026, Convertible Debt changed 0.33% year-over-year to $644.1 million; the TTM figure through Mar 2026 stood at $644.1 million (changed 0.33% YoY), while the FY2025 annual figure was $645.4 million, changed 0.33% from the prior year.
- Convertible Debt for Q1 2026 stood at $644.1 million, roughly flat from $645.4 million in the prior quarter.
- The five-year high for Convertible Debt was $896.8 million in Q1 2023, with the low at $644.1 million in Q1 2026.
- The 5-year median for Convertible Debt is $892.2 million (2023), against an average of $806.6 million.
- The sharpest annual moves came in 2024 and 2025: Convertible Debt advanced 0.13% in 2024, then slipped 27.77% in 2025.
- Pacific Biosciences Of California's Convertible Debt stood at $896.7 million in 2022, then decreased by 0.5% to $892.2 million in 2023, then decreased by 27.43% to $647.5 million in 2024, then slipped by 0.33% to $645.4 million in 2025, then retreated by 0.2% to $644.1 million in 2026.
- Business Quant data shows PACB's Convertible Debt at $644.1 million in Q1 2026, $645.4 million in Q4 2025, and $645.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 644.33 Mn |
| Mar 31, 2026 | 644.11 Mn |
| Dec 31, 2025 | 645.38 Mn |
| Sep 30, 2025 | 645.16 Mn |
| Jun 30, 2025 | 646.44 Mn |
| Mar 31, 2025 | 646.21 Mn |
| Dec 31, 2024 | 647.49 Mn |
| Sep 30, 2024 | 893.14 Mn |
| Jun 30, 2024 | 892.84 Mn |
| Mar 31, 2024 | 892.55 Mn |
| Dec 31, 2023 | 892.24 Mn |
| Sep 30, 2023 | 892.00 Mn |
| Jun 30, 2023 | 891.80 Mn |
| Mar 31, 2023 | 896.84 Mn |
| Dec 31, 2022 | 896.68 Mn |
| Sep 30, 2022 | 896.53 Mn |
| Jun 30, 2022 | 896.37 Mn |
| Mar 31, 2022 | 896.22 Mn |
| Dec 31, 2021 | 896.07 Mn |
| Jun 30, 2021 | 895.76 Mn |